Please login to the form below

Not currently logged in

EPEMED appoints Emmanuelle Benzimra as general delegate

Three board members also appointed including Janssen’s Wenrer Verbiest and GSK’s Peter Collins

Emmanuelle Benzimra - EPEMEDThe European Personalised Medicine association (EPEMED) has named Emmanuelle Benzimra as its general delegate, as well as three new additions to its board.

According to the not-for-profit, which aims to bring together companies and organisations involved in the progression of personalised medicine, Benzimra has experience in both the financial and investment banking industries as well as in supporting non-profit start-ups.

She is also currently in the middle of founding Bench2Cures, which aims to fund and accelerate the journey of products from laboratories to use in patients.

In addition to Benzimra's appointment, EPEMED added three new members to its board: Werner Verbiest, global head of Janssen Diagnostics; Peter Collins, head of diagnostics at GlaxoSmithKline (GSK); and Patrizia Luchetta, director of new technologies at the Ministry of the Economy and of Foreign Trade, Grand Duchy of Luxembourg.

Verbiest has played a leading role in progressing a personalised approach to medicine within Johnson & Johnson and Janssen, a company he originally joined in 1991. He has experience in the development of HIV drugs and hepatitis B vaccines.

Collins currently leads GSK's efforts to support the diagnostic needs of GSK's clinical development programmes across all business units.

He has over 30 years experience in the diagnostics industry, specialising in personalised medicines and companion diagnostics. His previous roles prior to joining GSK include VP pharma business development for Qiagen.

Patrizia Luchetta has been with the Ministry of Economy since 2006, helping to develop Luxembourg's health sciences and technologies hub and expand research opportunities in the country.

Benzimra said: “I am impressed by the dynamic that EPEMED created in such a short period and the body of leading experts it did attract.

“EPEMED is now in a pivotal position to represent a notorious centre of influence towards European institutions and governments for the mass introduction of personalised medicine in healthcare systems and harmonisation of practices for the benefit of patients.”

15th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

The truth is out there: Patients first
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what...
mHealth: The revolution will not be digital
Could mHealth, which has been growing exponentially in recent years, be the answer we have been looking for to address our population health challenge? Could mHealth save healthcare?...
Medical information in precision medicine
Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine....